Written by
Mustafa Çelik
Mustafa Çelik Liv Hospital Content Team
Medically reviewed by

Related Doctors

Assoc. Prof. MD. Evrim Duman Liv Hospital Ulus Assoc. Prof. MD. Evrim Duman Radiation Oncology Asst. Prof. MD. Meltem Topalgökçeli Selam Liv Hospital Ulus Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology Prof. MD. Duygu Derin Liv Hospital Ulus Prof. MD. Duygu Derin Medical Oncology Prof. MD. Emre Merdan Fayda Liv Hospital Ulus Prof. MD. Emre Merdan Fayda Radiation Oncology Prof. MD. Meral Günaldı Liv Hospital Ulus Prof. MD. Meral Günaldı Medical Oncology Assoc. Prof. MD. Murat Ayhan Liv Hospital Vadistanbul Assoc. Prof. MD. Murat Ayhan Medical Oncology Prof. MD.  Itır Şirinoğlu Demiriz Liv Hospital Vadistanbul Prof. MD. Itır Şirinoğlu Demiriz Hematology Prof. MD. Tülin Tıraje Celkan Liv Hospital Vadistanbul Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology Assoc. Prof. MD. Erkan Kayıkçıoğlu Liv Hospital Bahçeşehir Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology Assoc. Prof. MD. Mine Dağgez Liv Hospital Bahçeşehir Assoc. Prof. MD. Mine Dağgez Gynecological Oncology Assoc. Prof. MD. Ozan Balakan Liv Hospital Bahçeşehir Assoc. Prof. MD. Ozan Balakan Medical Oncology MD. Taylan Bükülmez Liv Hospital Bahçeşehir MD. Taylan Bükülmez Radiation Oncology Op. MD. Alp Koray Kinter Liv Hospital Bahçeşehir Op. MD. Alp Koray Kinter Gynecological Oncology Prof. MD. Nuri Faruk Aykan Liv Hospital Bahçeşehir Prof. MD. Nuri Faruk Aykan Medical Oncology Spec. MD. Özlem Doğan Liv Hospital Bahçeşehir Spec. MD. Özlem Doğan Medical Oncology Assoc. Prof. MD. Emir Çelik Liv Hospital Topkapı Assoc. Prof. MD. Emir Çelik Medical Oncology Assoc. Prof. MD. Muhammed Mustafa Atcı Liv Hospital Topkapı Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology Prof. MD. İrfan Çiçin Liv Hospital Topkapı Prof. MD. İrfan Çiçin Medical Oncology Assoc. Prof. MD.  Ramazan Öcal Liv Hospital Ankara Assoc. Prof. MD. Ramazan Öcal Hematology Assoc. Prof. MD. Nazlı Topfedaisi Özkan Liv Hospital Ankara Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology Prof. MD. Fikret Arpacı Liv Hospital Ankara Prof. MD. Fikret Arpacı Medical Oncology Prof. MD. Gökhan Erdem Liv Hospital Ankara Prof. MD. Gökhan Erdem Medical Oncology Prof. MD. Meral Beksaç Liv Hospital Ankara Prof. MD. Meral Beksaç Hematology Prof. MD. Oral Nevruz Liv Hospital Ankara Prof. MD. Oral Nevruz Hematology Prof. MD. Saadettin Kılıçkap Liv Hospital Ankara Prof. MD. Saadettin Kılıçkap Medical Oncology Prof. MD. Sadık Muallaoğlu Liv Hospital Ankara Prof. MD. Sadık Muallaoğlu Medical Oncology Spec. MD. Ender Kalacı Liv Hospital Ankara Spec. MD. Ender Kalacı Medical Oncology Assoc. Prof. MD. Fadime Ersoy Dursun Liv Hospital Gaziantep Assoc. Prof. MD. Fadime Ersoy Dursun Hematology Prof. MD. Fatih Teker Liv Hospital Gaziantep Prof. MD. Fatih Teker Medical Oncology Spec. MD. ELXAN MEMMEDOV Liv Bona Dea Hospital Bakü Spec. MD. ELXAN MEMMEDOV Medical Oncology Spec. MD. Ceyda Aslan Spec. MD. Ceyda Aslan Hematology Spec. MD. Elkhan Mammadov Spec. MD. Elkhan Mammadov Medical Oncology Spec. MD. Elmir İsrafilov Spec. MD. Elmir İsrafilov Hematology Spec. MD. Minure Abışova Eliyeva Spec. MD. Minure Abışova Eliyeva Hematology Spec. MD. Natavan Azizova Spec. MD. Natavan Azizova Medical Oncology Prof. MD. Mehmet Hilmi Doğu Liv Hospital Ulus + Liv Hospital Bahçeşehir Prof. MD. Mehmet Hilmi Doğu Hematology
...
Views
Read Time
...
views
Read Time
Lung Cancer Survival Rate: Amazing Growth
Lung Cancer Survival Rate: Amazing Growth 4

As we get older, the chance of getting lung cancer goes up a lot. The CDC and National Cancer Institute say more than 60% of new cases happen to people 65 or older.

The lung cancer survival rate is seeing amazing growth. Learn powerful facts about age and how to beat scary statistics with early care.

The age when most people get lung cancer is between 65 and 74. The average age when people are diagnosed is 71. Knowing this helps us understand the disease better and find better ways to screen and treat it.

We need to focus on the needs of older people. This is because the world’s population is getting older, and lung cancer cases are expected to keep going up.

Key Takeaways

  • The median age at diagnosis for lung cancer is 71 years.
  • Over 60% of new lung cancer cases occur in individuals aged 65 or older.
  • The most common age for lung cancer diagnosis is between 65 and 74 years.
  • Understanding the demographic trends is key for better screening and treatment plans.
  • The number of lung cancer cases is expected to rise as the world’s population ages.

The Age Distribution of Lung Cancer

Lung Cancer Survival Rate: Amazing Growth
Lung Cancer Survival Rate: Amazing Growth 5

Age is key in lung cancer development and diagnosis. As we get older, the risk of lung cancer grows. This is because of factors like smoking and environmental exposures that build up over time.

Overview of Lung Cancer Prevalence by Age

Lung cancer mostly affects older adults, with most cases found in those 65 or older. The risk jumps up after 50. It’s very rare for lung cancer to be found in people under 45.

Age Group

Incidence Rate per 100,000

Under 45

Rare

45-54

20.4

55-64

104.4

65-74

204.9

75-79

234.1

Why Age Is a Critical Factor in Lung Cancer

Age matters in lung cancer because of more exposure to harmful substances over time. Older people’s immune systems weaken, and genetic changes add up. Knowing how lung cancer changes with age helps in creating better screening and treatment plans for seniors.

We understand that lung cancer symptoms in women and stage 4 lung cancer survival rate by age are key when talking about lung cancer and age. Our study shows how age affects lung cancer survival rates by age.

Peak Age Range for Lung Cancer Diagnosis: 65-74 Years

Lung cancer diagnosis peaks between 65 and 74 years old. This age range is key for screening and early detection. It’s a time when the risk of lung cancer is much higher.

The median age at diagnosis is 71 years. This means most patients are diagnosed in their early seventies. Knowing this helps healthcare providers focus their screening efforts.

Statistical Evidence for the 65-74 Age Range

More than 60% of new lung cancer cases happen in people aged 65 or older. This shows how important age is in lung cancer diagnosis. It also points to the need for targeted screening programs.

“The peak age range for lung cancer diagnosis is between 65 and 74 years, highlighting the need for careful screening in this group.”

Median Age of 71 at Diagnosis

The median age of 71 at diagnosis is a key number. It shows that half of lung cancer patients are diagnosed before this age, and the other half after. This median age helps us understand the age distribution of lung cancer patients.

Knowing the age dynamics of lung cancer diagnosis helps tailor screening and treatment. As we look at lung cancer statistics, age is a key factor in treatment success.

By focusing on the 65-74 age range, healthcare providers can improve early detection. This could lead to better lung cancer survival rates by stage and age.

Understanding Age-Related Incidence Rates

Lung Cancer Survival Rate: Amazing Growth
Lung Cancer Survival Rate: Amazing Growth 6

Lung cancer rates go up sharply after the age of 50. This is because the body’s ability to fix DNA damage gets worse with age. Older adults are more likely to get lung cancer because of this.

The Sharp Rise After Age 50

After 50, lung cancer cases start to rise fast. This is because of years of exposure to harmful substances like tobacco smoke and pollution. The risk keeps growing as people get into their 60s and 70s.

The 75-79 Age Group: Highest Rate per 100,000

The 75-79 age group has the highest lung cancer rate per 100,000 people. They are more at risk because of years of exposure to harmful factors. Knowing this helps doctors plan better screening and treatment plans.

To show how age affects lung cancer rates, we’ve made a table:

Age Group

Incidence Rate per 100,000

50-54

120

55-59

150

60-64

180

65-69

220

70-74

250

75-79

280

The table shows the highest rate is in the 75-79 age group. This highlights the need for more checks and prevention in this age group. Knowing lung cancer symptoms in men and stage3 lung cancer survival rate by age can help patients a lot.

By understanding lung cancer trends by age, we can make our screening and treatment plans better. This can help improve care and possibly lead to more lung cancer survival stories.

Lung Cancer in Younger Adults: Under 45

Lung cancer is rare in people under 45. It’s a big challenge because it’s not common in young adults. We need to understand it well to treat it effectively.

Rarity of Lung Cancer in Young Adults

Lung cancer is very rare in those under 35. Studies show it’s much less common in young people than in older ones. This makes it hard to catch early because no one suspects it at first.

Key statistics on lung cancer incidence in younger adults include:

Age Group

Incidence Rate per 100,000

Under 35

1.2

35-44

4.5

45 and above

Significantly higher

Unique Characteristics of Early-Onset Lung Cancer

Early-onset lung cancer is different from the kind in older people. It has unique genetic changes and often runs in families. Younger patients tend to have a specific type of lung cancer with certain genetic changes.

“The genetic landscape of early-onset lung cancer is distinct, with a higher prevalence of certain mutations that can be targeted with specific therapies.”

It’s important to understand these differences to create better treatments for young patients. We also need to look at what causes lung cancer in young people, like environmental factors and genetics.

By knowing how rare and unique lung cancer is in young adults, we can aim for earlier detection and better treatments for them.

Lung Cancer Survival Rate Across Different Age Groups

Lung cancer survival rates change a lot with age. Age is a big factor in how well someone can survive. We’ll look at how age affects survival and compare survival rates by age group.

Impact of Age on Overall Survival

When you get lung cancer, your age matters a lot. Older people usually don’t live as long as younger ones. This is because older adults often have other health problems and aren’t as strong.

Age-related decline in physical condition and other health issues make treatment harder. This can affect how long someone lives after being diagnosed.

We’ve noticed that:

  • Younger patients (under 45) usually do better because they’re healthier.
  • People between 65 and 74 often get lung cancer more. Their survival depends on their health at that age.
  • Older adults (75 and above) struggle more because of health problems and can’t handle tough treatments as well.

Comparing Survival Statistics by Decade of Life

Looking at survival rates by age shows age is key. Younger people tend to live longer than older ones. This is because older people face more health challenges.

Here’s a look at 5-year survival rates by age:

Age Group

5-Year Survival Rate

Under 45

Higher survival rates, often above 50%

65-74

Moderate survival rates, around 20-30%

75 and above

Lower survival rates, often below 15%

Knowing these differences helps us tailor treatments better. It’s important to meet the specific needs of each age group. This way, we can improve survival chances for everyone.

Stage-Specific Lung Cancer Survival Rates by Age

The stage of lung cancer diagnosis and the patient’s age are key factors in survival. Knowing these details helps doctors create better treatment plans. It also gives patients a clear idea of what to expect.

Early-Stage (I-II) Survival Rates Across Age Groups

Early-stage lung cancer (stages I-II) has better survival rates. Younger patients often do better in these cases. Early detection and treatment are key to improving survival chances.

Recent studies show that those under 65 with stage I lung cancer have a higher 5-year survival rate. This shows how important age is in survival. It also points to the need for treatments that fit each patient’s age and health.

Advanced-Stage (III-IV) Survival Rates Across Age Groups

Advanced-stage lung cancer (stages III-IV) has lower survival rates. Age has a bigger impact on survival in these cases. Advances in treatment are vital for improving survival for these patients.

Survival rates for advanced-stage lung cancer are lower for everyone. But, there’s a big difference in survival between younger and older patients. For example, those under 55 with stage III lung cancer tend to live longer than those over 75. This shows the need for personalized treatment plans that consider age, health, and disease specifics.

Gender and Age: Differences in Lung Cancer Patterns

Age and gender are key in lung cancer patterns and symptoms. Knowing these differences helps create better screening and treatment plans for different groups.

Lung Cancer Symptoms in Women by Age

Lung cancer symptoms in women change with age. Younger women often get adenocarcinoma, a type of lung cancer. They might feel a persistent cough, chest pain, or shortness of breath.

In older women, symptoms can be less clear. They might seem like other health issues, making it hard to catch lung cancer early.

Common symptoms in women include:

  • Persistent cough
  • Chest pain or discomfort
  • Shortness of breath
  • Coughing up blood or rust-colored mucus
  • Recurring respiratory infections

Age Group

Common Symptoms

Under 45

Cough, chest pain, shortness of breath

45-64

Coughing up blood, recurring infections

65+

Nonspecific symptoms, often attributed to other conditions

Symptoms of Lung Cancer in Men by Age

Men also see different symptoms of lung cancer at different ages. Older men face a higher risk and often have more severe symptoms. Symptoms can include cough, chest pain, and trouble swallowing.

Notably, men are more likely than women to experience:

  • Difficulty swallowing
  • Wheezing or hoarseness
  • Swelling in the neck or face

Knowing these age and gender differences helps doctors better diagnose and treat lung cancer. This can lead to earlier detection and more effective treatments.

Risk Factors That Influence Age of Diagnosis

Lung cancer diagnosis age is shaped by several factors, like smoking and environmental exposures. Knowing these factors helps us spot high-risk groups. It also guides us in creating effective prevention plans.

Smoking History and Its Impact on Age of Onset

Smoking is a major lung cancer risk factor, affecting when it’s diagnosed. Long-term smokers face a higher risk of lung cancer at a younger age. The American Cancer Society says smoking causes 80 to 90 percent of lung cancer deaths.

A leading oncologist, notes, “Quitting smoking is key to lowering lung cancer risk. It’s never too late to stop.”

“The risk of lung cancer is 15 to 30 times higher in smokers than in non-smokers.”

Secondhand smoke also raises lung cancer risk, though it’s less than for smokers. This shows why avoiding smoke is vital.

Environmental, Occupational, and Genetic Factors

Smoking isn’t the only risk. Environmental and job-related exposures also matter. For example, asbestos and radon in the workplace increase lung cancer risk. Asbestos can cause lung cancer and mesothelioma, a rare lung cancer type.

Genetics also play a part. Family history of lung cancer ups the risk, even with smoking. Genetic changes, like in the EGFR gene, can affect lung cancer type and risk.

Combining these risks can greatly increase lung cancer risk at a younger age. So, understanding and reducing these risks is key for prevention and early detection.

Age-Appropriate Screening Recommendations

Age is key in lung cancer screening. Guidelines suggest screening for those 50 to 74 years old. This age is important because lung cancer risk grows after 50.

Current Guidelines for Lung Cancer Screening by Age

The U.S. Preventive Services Task Force (USPSTF) sets guidelines for lung cancer screening. They suggest annual scans for those 50 to 74 with a 20 pack-year smoking history. This includes current smokers or those who quit in the last 15 years. These rules help find high-risk people early.

Age Group

Screening Recommendation

Risk Factors

50-74 years

Annual LDCT screening

20 pack-year smoking history, current smoker or quit within 15 years

Under 50 years

No routine screening recommended

High-risk individuals may be considered for screening

75 years and older

Screening decision based on individual health status

Consider overall health, life expectancy, and risk factors

The Debate on Extending Screening to Other Age Groups

There’s a debate on screening younger or older people. Some think those under 50 with high risk should be screened. Others worry about the risks for older adults with health issues. The choice depends on individual risk and health.

Guidelines are changing, and healthcare providers need to keep up. This ensures those at risk get the right care. It helps improve lung cancer outcomes.

Treatment Approaches Based on Patient Age

The age of a patient is key in choosing the right lung cancer treatment. Age affects the type and intensity of care needed.

Treatment Considerations for Elderly Patients (65+)

Elderly patients, aged 65 and up, need special care for lung cancer. Their health, other health issues, and how well they can handle treatment are important. We must think about the benefits and risks of treatment and how it affects their life quality.

  • Comprehensive Geriatric Assessment: This helps us understand the patient’s health, other conditions, and support system. It guides us in creating treatment plans that fit their needs.
  • Tailored Treatment Plans: Treatment for older patients is adjusted to their specific needs. This might include changing how much chemotherapy they get or using targeted therapies.

Aggressive vs. Conservative Treatment by Age Group

Choosing between aggressive and conservative treatments depends on several factors. These include the patient’s age, health, and lung cancer stage. Younger patients might handle aggressive treatments better. But older patients might do better with a more gentle approach, focusing on quality of life.

  1. Aggressive Treatment: Younger patients or those with fewer health issues might get intensive treatments like surgery, chemotherapy, or a mix of treatments.
  2. Conservative Treatment: Elderly patients or those with many health issues might get treatments that focus on managing symptoms and improving comfort.

Every patient is different, and treatment choices should be made with their unique needs in mind. We consider their preferences, values, and health condition when deciding.

Improving Lung Cancer Survival Rate: Modern Approaches

The way we treat lung cancer is changing. Teams of doctors are working together to help patients live longer. We’re learning more about lung cancer and finding new ways to treat it, helping people of all ages.

Age-Specific Treatment Innovations

Today, lung cancer treatment is more tailored to each person. Targeted therapies and immunotherapies are showing great promise. They’re made to match the unique needs of each patient’s lung cancer.

Studies show that immunotherapy works well for older adults. They often have more health issues. A study found that immunotherapy helps older patients with lung cancer live longer and feel better.

“The integration of immunotherapy into treatment protocols has revolutionized the way we approach lung cancer, even for older adults.”

Here’s a quick look at some age-specific treatments:

Age Group

Treatment Approach

Key Benefits

65-74 years

Targeted therapy and surgery

Improved survival rates, fewer side effects

75+ years

Immunotherapy and palliative care

Enhanced quality of life, manageable side effects

Multidisciplinary Care for Different Age Groups

Teams of doctors are key in fighting lung cancer. They work together to create the best treatment plans. Younger patients might get more aggressive treatments like surgery and chemotherapy.

Older patients might get treatments that focus on quality of life. A top oncologist says, “The best treatment is one that fits the patient’s needs, considering their age, health, and wishes.”

Using a team approach ensures that all patients get the right treatment. This not only helps them live longer but also improves their care overall.

Liv Hospital’s Approach to Age-Specific Lung Cancer Care

Liv Hospital focuses on lung cancer care for all ages. We understand each patient’s needs are different. Our goal is to provide top-notch, ethical healthcare for lung cancer treatment.

Advanced Diagnostics for Early Detection Across Age Groups

At Liv Hospital, we use the latest diagnostic tools to find lung cancer early. This is true for patients of any age. Our tools include high-resolution imaging and molecular testing. They help us understand each patient’s cancer better.

Diagnostic Capabilities:

Diagnostic Tool

Description

Benefit

High-Resolution Imaging

Detailed imaging of the lungs

Early detection of tumors

Molecular Testing

Analysis of genetic markers

Personalized treatment planning

Personalized Treatment Protocols Based on Age and Condition

Our team creates treatment plans that fit each patient’s needs. We consider their age, health, and lung cancer type. This ensures patients get the best care possible.

Our treatment protocols include:

  • Surgery
  • Chemotherapy
  • Targeted therapy
  • Immunotherapy

Liv Hospital combines advanced diagnostics with personalized treatment. This approach gives age-specific lung cancer care that meets each patient’s unique needs.

Conclusion

It’s key to understand how age affects lung cancer. Most people get diagnosed between 65 and 74 years old. This shows we need to tailor our approach to each age group.

Age is a big factor in lung cancer survival rates. Our studies show the importance of treatments that fit each patient’s needs. This way, we aim to boost survival chances.

At Liv Hospital, we focus on top-notch, personalized care for lung cancer patients. Our team uses the latest in diagnostics and treatments. We aim to support patients and their families fully. Through ongoing research and a patient-first approach, we hope to make a difference in survival rates.

FAQ

What is the most common age range for lung cancer diagnosis?

Most lung cancer cases happen between 65 and 74 years old. The average age at diagnosis is 71 years.

How does age impact lung cancer incidence rates?

After 50, lung cancer rates jump up. Most cases are in people 65 or older.

Are there differences in lung cancer symptoms between men and women across different age groups?

Yes, men and women show different symptoms. These can change with age. This shows why we need specific screening and treatments for each gender.

What are the key risk factors that influence the age of lung cancer diagnosis?

Risk factors include smoking, environmental exposures, job hazards, and genetics. Smoking is a big factor in when lung cancer starts.

What are the current guidelines for lung cancer screening based on age?

Guidelines suggest screening for those 50 to 74 years old. This depends on risk. There’s debate about screening younger or older people.

How does age affect lung cancer survival rates?

Older people usually have lower survival rates. This is because of other health issues and less energy.

What is the impact of age on stage-specific lung cancer survival rates?

Age affects survival at all stages. Older patients often do worse. This shows we need treatments tailored to age.

How do treatment approaches for lung cancer vary based on patient age?

For those 65+, treatment choices are based on health and other factors. Decisions are between aggressive and gentle treatments.

What modern approaches are being used to improve lung cancer survival rates across different age groups?

New treatments like targeted and immunotherapies are helping. Also, teams of doctors work together to tailor care for each age group.

Can lung cancer occur in younger adults, and what are its characteristics?

Yes, lung cancer can happen in younger people, though it’s rare. Early cases often have unique genes and a strong family history.

References:

Healthline. (n.d.). Lung cancer and age: Statistics, risk factors, and more. https://www.healthline.com/health/lung-cancer/lung-cancer-age

• SEER. (n.d.). Lung and bronchus cancer — Cancer stat facts. https://seer.cancer.gov/statfacts/html/lungb.html

• National Cancer Institute. (n.d.). Risk factors: Age. https://www.cancer.gov/about-cancer/causes-prevention/risk/age

• Cancer Research UK. (n.d.). Lung cancer incidence statistics. https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/lung-cancer/incidence

• CDC. (n.d.). Lung cancer statistics. https://www.cdc.gov/cancer/lung/statistics/age.htm

i

Medical Disclaimer

The content on this page is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Always consult a qualified healthcare provider regarding any medical conditions.

Book a Free Certified Online
Doctor Consultation

Clinics/branches
GDPR

We're Here to Help.
Get in Touch

Send us all your questions or requests, and our
expert team will assist you.

Our Doctors

Assoc. Prof. MD. Evrim Duman Radiation Oncology

Assoc. Prof. MD. Evrim Duman

Liv Hospital Ulus
Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology

Asst. Prof. MD. Meltem Topalgökçeli Selam

Liv Hospital Ulus
Prof. MD. Duygu Derin Medical Oncology

Prof. MD. Duygu Derin

Liv Hospital Ulus
Prof. MD. Emre Merdan Fayda Radiation Oncology

Prof. MD. Emre Merdan Fayda

Liv Hospital Ulus
Prof. MD. Mehmet Hilmi Doğu Hematology

Prof. MD. Mehmet Hilmi Doğu

Liv Hospital Ulus
Liv Hospital Bahçeşehir
Prof. MD. Meral Günaldı Medical Oncology

Prof. MD. Meral Günaldı

Liv Hospital Ulus
Assoc. Prof. MD. Murat Ayhan Medical Oncology

Assoc. Prof. MD. Murat Ayhan

Liv Hospital Vadistanbul
Prof. MD.  Itır Şirinoğlu Demiriz Hematology

Prof. MD. Itır Şirinoğlu Demiriz

Liv Hospital Vadistanbul
Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology

Prof. MD. Tülin Tıraje Celkan

Liv Hospital Vadistanbul
Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology

Assoc. Prof. MD. Erkan Kayıkçıoğlu

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Mine Dağgez Gynecological Oncology

Assoc. Prof. MD. Mine Dağgez

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Ozan Balakan Medical Oncology

Assoc. Prof. MD. Ozan Balakan

Liv Hospital Bahçeşehir
MD. Taylan Bükülmez Radiation Oncology

MD. Taylan Bükülmez

Liv Hospital Bahçeşehir
Op. MD. Alp Koray Kinter Gynecological Oncology

Op. MD. Alp Koray Kinter

Liv Hospital Bahçeşehir
Prof. MD. Nuri Faruk Aykan Medical Oncology

Prof. MD. Nuri Faruk Aykan

Liv Hospital Bahçeşehir
Spec. MD. Özlem Doğan Medical Oncology

Spec. MD. Özlem Doğan

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Emir Çelik Medical Oncology

Assoc. Prof. MD. Emir Çelik

Liv Hospital Topkapı
Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology

Assoc. Prof. MD. Muhammed Mustafa Atcı

Liv Hospital Topkapı
Prof. MD. İrfan Çiçin Medical Oncology

Prof. MD. İrfan Çiçin

Liv Hospital Topkapı
Assoc. Prof. MD.  Ramazan Öcal Hematology

Assoc. Prof. MD. Ramazan Öcal

Liv Hospital Ankara
Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology

Assoc. Prof. MD. Nazlı Topfedaisi Özkan

Liv Hospital Ankara
Prof. MD. Fikret Arpacı Medical Oncology

Prof. MD. Fikret Arpacı

Liv Hospital Ankara
Prof. MD. Gökhan Erdem Medical Oncology

Prof. MD. Gökhan Erdem

Liv Hospital Ankara
Prof. MD. Meral Beksaç Hematology

Prof. MD. Meral Beksaç

Liv Hospital Ankara
Prof. MD. Oral Nevruz Hematology

Prof. MD. Oral Nevruz

Liv Hospital Ankara
Prof. MD. Saadettin Kılıçkap Medical Oncology

Prof. MD. Saadettin Kılıçkap

Liv Hospital Ankara
Prof. MD. Sadık Muallaoğlu Medical Oncology

Prof. MD. Sadık Muallaoğlu

Liv Hospital Ankara
Spec. MD. Ender Kalacı Medical Oncology

Spec. MD. Ender Kalacı

Liv Hospital Ankara
Assoc. Prof. MD. Fadime Ersoy Dursun Hematology

Assoc. Prof. MD. Fadime Ersoy Dursun

Liv Hospital Gaziantep
Prof. MD. Fatih Teker Medical Oncology

Prof. MD. Fatih Teker

Liv Hospital Gaziantep
Spec. MD. ELXAN MEMMEDOV Medical Oncology

Spec. MD. ELXAN MEMMEDOV

Liv Bona Dea Hospital Bakü
Spec. MD. Ceyda Aslan Hematology

Spec. MD. Ceyda Aslan

Spec. MD. Elkhan Mammadov Medical Oncology

Spec. MD. Elkhan Mammadov

Spec. MD. Elmir İsrafilov Hematology

Spec. MD. Elmir İsrafilov

Spec. MD. Minure Abışova Eliyeva Hematology

Spec. MD. Minure Abışova Eliyeva

Spec. MD. Natavan Azizova Medical Oncology

Spec. MD. Natavan Azizova

Need Help? Chat with our medical team

Let's Talk on WhatsApp

📌

Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.

or call us at +90 530 510 67 91